Pfizer's candidate, giroctocogene fitelparvovec, met its primary and key secondary objectives of superiority compared to the standard treatment of regular Factor VIII infusions. https://hubs.li/Q02HNR8Y0 #pharma #hemophilia #biospace
BioSpace
Internet News
West Des Moines, Iowa 113,716 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Head of Insights
Updates
-
A longtime biopharma exec and Moderna shareholder argues in an anonymous email to the companies’ CFOs that they have a fiduciary responsibility to close the deal with Merck. Analysts say the proposal is interesting but “too simplistic.” https://hubs.li/Q02HNlhX0
Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?
biospace.com
-
Biopharma Layoff Tracker 2024: More cut staff including Merck, RAPT Therapeutics and Aslan. https://hubs.li/Q02HNn090 #layoffs #pharma #biotech #lifesciences #biospace
Biopharma Layoff Tracker 2024: Merck, Rapt, Aslan and More Cut Staff
biospace.com
-
Biogen and Sage Therapeutics' investigational neuroactive steroid did not significantly improve upper limb tremors in patients with essential tremor, the companies announced Wednesday. https://hubs.li/Q02HNh5w0 #clinicaltrials #pharma #biospace
Biogen, Sage Scrap Essential Tremor Study After Phase II Failure
biospace.com
-
AstraZeneca is proposing to use Imfinzi for resectable non-small cell lung cancer in the perioperative setting—both before and after surgical resection of the tumor. However, ahead of Thursday’s advisory committee meeting, FDA staffers have expressed concerns. https://hubs.li/Q02HNfL50 #pharma #oncology #biospace
FDA Flags Potential ‘Overtreatment’ for NSCLC With AstraZeneca’s Imfinzi Ahead of Adcomm
biospace.com
-
Executives from the three largest pharmacy benefit manager companies (CVS Caremark, OptumRx & Express Scripts by Evernorth) testified Tuesday before Congress that rising drug prices in the U.S. are due to pharma companies taking advantage of market exclusivities and excessive charges. https://hubs.li/Q02HM-g10 #pharma #finance #legal #biospace
PBM Execs Point Fingers at Pharma Industry in House Hearing on Rising Drug Prices
biospace.com
-
Third Arc Bio, led by three former Johnson & Johnson executives, is advancing a portfolio of multifunctional antibodies for cancer and inflammatory and immune-mediated diseases. https://hubs.li/Q02HM-KX0 #pharma #oncology #biospace
J&J Alums Raise $165M Series A for Startup to Develop Biologics for Cancer, Autoimmune Diseases
biospace.com
-
BioSpace's 2024 U.S. Life Sciences Job Market Trends, H2 Update investigates anticipated job search activity and the hiring outlook for the remainder of 2024. Download your free copy today: https://hubs.li/Q02HPq7N0 #jobmarket #lifesciences #biospace
Report: 2024 Job Market Trends, H2 Update
-
Despite early 2024 optimism, BioSpace’s Job Market Trends report outlines a still sluggish situation in the biopharma industry, Novartis and Johnson & Johnson announce Q2 earnings, GLP-1 market leaders expand into China and the Cassava Sciences saga continues. Tune in to the latest episode of The Weekly with Heather McKenzie, Greg Slabodkin, Jennifer "Jef" Akst and Chantal Dresner: https://hubs.li/Q02HM_Q80
Layoffs Persist, GLP-1s Launch for Weight Loss in China
biospace.com
-
While supportive of Amylyx Pharmaceuticals' acquisition of a GLP-1 drug, analysts say the company’s future hinges on key upcoming readouts from multiple products in its pipeline. https://hubs.li/Q02HM-ng0 #pharma #GLP1 #biospace
Amylyx Rebuilds Momentum Following Relyvrio Market Withdrawal
biospace.com